Back to top

insurance: Archive

Zacks Equity Research

MGIC Investment Trades Near 52-Week High: Time to Hold the Stock?

MTG gains from strong new business, healthier housing activity, declining claims, and robust capital.

Rajshree Sipani

Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised)

CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.

Tanuka De

BRK.B Stock Outperforms Industry, Trades at a Premium: Should You Buy?

BRK.B trades at a premium with mixed earnings signals and modest returns, despite outperforming its industry YTD.

Rajshree Sipani

Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?

CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.

Shrabana Mukherjee

5 Women-Run Companies Reshaping Portfolios With Consistent Growth

GM, SPGI, RL, M and GAP show how women-led companies are redefining growth with discipline, agility and results.

Zacks Equity Research

New Strong Buy Stocks for Nov. 26: JRVR, CMC, and More

WTBA, JRVR, CMC, PAAS and AEM have been added to the Zacks Rank #1 (Strong Buy) List on Nov. 26, 2025.

Tanuka De

Here's How BH Primary Group Fuels BRK.B's Insurance Operations

Berkshire Hathaway's insurance strength gets a steady boost from Berkshire Hathaway Primary Group???s durable, diversified underwriting engine.

Tanuka De

PGR's Net Margin Shows Improvement: Can it Retain the Momentum?

Progressive's net margin gains, tech-driven underwriting and planned rate hikes raise the question of whether momentum can continue.

Zacks Equity Research

Steady Reward: Is Marsh & McLennan a Keeper or Just Comfortable?

MMC leans on consulting strength, rising estimates and steady cash flow as it targets continued growth.

Tanuka De

Progressive's October Earnings Rise: Here's How to Play the Stock

PGR's October surge in EPS, revenues and policy growth highlights strengthening momentum despite recent share underperformance.